- +1 551 333 1547
- +44 2070 979277
- live:skype_chat
Request Discount Coupon
View Synopsis & Table of Content
Glial Cell Line Derived Neurotrophic Factor Comprehensive Study by Type (GSK-812, LAUR-301, TW-002, AMT-090, Other), Application (Amyotrophic Lateral Sclerosis, Brain Ischemia, Parkinson’s Disease, Retinal Degeneration, Others) Players and Region - Global Market Outlook to 2030
Glial Cell Line Derived Neurotrophic Factor Market by Key Segments | Forecast Years: 2024- 2030 | CAGR:7.6%
{reportSlug=global-glial-cell-line-derived-neurotrophic-factor-market, reportId=99690, mktKeyword=Glial Cell Line Derived Neurotrophic Factor, cagr=7.60, publishDate=Feb 2024, priceOption2=6500, reportTitle=Glial Cell Line Derived Neurotrophic Factor Comprehensive Study by Type (GSK-812, LAUR-301, TW-002, AMT-090, Other), Application (Amyotrophic Lateral Sclerosis, Brain Ischemia, Parkinson’s Disease, Retinal Degeneration, Others) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=199, priceOption1=3350, forecastYr=2030, noOfPages=197, reportKey=99219, breadcrum=Global Glial Cell Line Derived Neurotrophic Factor Market}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Feb 2024
197 Pages
92 Tables
Base Year: 2023
Coverage: 15+ Companies; 18
Countries
Connect with Us
